Filing Flows › Nexgel (NXGL) › Q1 2025
Nexgel (NXGL) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 13, 2025
Nexgel (NXGL) reported revenue of $2.8M for the first quarter 2025 (Q1 2025), +122% from a year earlier and -8% from the quarter before. Operating margin was -27.7%, net loss $678K (24.2% of revenue).
Nexgel, Q1 2025: revenue $2.8M (+122% year over year), operating margin -27.7%, net loss $678K, operating cash flow −$400K. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.8M | -8% | +122% |
| Operating profit | −$777K | — | — |
| Net earnings | −$678K | — | — |
| Operating cash flow | −$400K | — | — |
What changed
Revenue was $2.8M in Q1 2025, up 122% year over year and down 8% from the previous quarter.
Gross margin was 42.3%, up 29.7 points from a year earlier. Operating costs exceeded revenue by $777K, an operating margin of -27.7%. Operating expenses grew 91% against revenue growth of 122%. The fastest-growing cost line was SG&A (+91%). The quarter ended with a net loss of $678K, narrower than the previous quarter's $824K loss.
Operating cash flow was −$400K. Non-cash charges added back $114K of depreciation and amortization and $166K of share-based compensation.
Questions
What was Nexgel's revenue in the first quarter 2025?
Nexgel (NXGL) reported revenue of $2.8M for the first quarter 2025 (Q1 2025), +122% from a year earlier and -8% from the quarter before.
Was Nexgel profitable in the first quarter 2025?
Operating loss was $777K (-27.7% of revenue) and net loss $678K.
Source: Nexgel 10-Q on SEC EDGAR.